Iodothyronine deiodinase

4TR3

Iodothyronine deiodinase

Iodothyronine deiodinase is a group of enzymes that are critical for the metabolism and action of thyroid hormones. Thyroid hormones, such as thyroxine (T4) and triiodothyronine (T3), play a vital role in regulating various biological processes including metabolism, growth, and development. The deiodinases are responsible for the activation and deactivation of these hormones through the removal of iodine atoms from the thyroid hormones' molecular structure.

Types of Iodothyronine Deiodinases

There are three main types of iodothyronine deiodinases, each with distinct functions, locations, and substrate specificities:

• Type I deiodinase (DIO1) is primarily found in the liver, kidney, and thyroid gland. It is involved in the conversion of T4 to the more active T3 by removing an iodine atom from the outer ring. DIO1 also contributes to the clearance of reverse T3 (rT3), an inactive metabolite.
• Type II deiodinase (DIO2) is expressed in the brain, pituitary gland, brown adipose tissue, and in the thyroid gland itself. DIO2 plays a crucial role in providing T3 to these tissues, particularly the brain, by converting T4 to T3 locally.
• Type III deiodinase (DIO3) is found in the placenta, central nervous system, and skin. It inactivates thyroid hormones by removing an iodine atom from the inner ring, converting T4 to reverse T3 (rT3) and T3 to 3,3'-diiodothyronine (T2), both of which are biologically inactive.

Function and Regulation

The primary function of iodothyronine deiodinases is to regulate the levels of active and inactive thyroid hormones both in the bloodstream and within specific tissues. This regulation is crucial for maintaining homeostasis and ensuring that tissues receive the appropriate amount of thyroid hormones according to their needs.

The activity of deiodinases is influenced by various factors, including nutritional status, hormones, and stress. For example, selenium deficiency can reduce the activity of all three deiodinases, as selenium is a cofactor for these enzymes. Additionally, certain hormones and cytokines can modulate deiodinase expression and activity in response to physiological changes.

Clinical Significance

Alterations in deiodinase activity can have significant clinical implications. For instance, in illnesses such as non-thyroidal illness syndrome (NTIS), there is a reduction in DIO1 and DIO2 activities, leading to decreased levels of T3 despite normal or low-normal T4 levels. This condition is thought to represent an adaptive response to illness.

Understanding the role of deiodinases in thyroid hormone metabolism has also led to the development of therapeutic strategies for managing thyroid-related disorders. For example, drugs that inhibit DIO3 could potentially be used to increase T3 levels in certain conditions.

Research Directions

Research into iodothyronine deiodinases continues to uncover their complex roles in health and disease. Studies are exploring the potential of targeting deiodinase activity to treat metabolic diseases, such as obesity and diabetes, as well as psychiatric disorders, where altered thyroid hormone metabolism has been implicated.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian